TAC1 and schizophrenia: The present study revealed that there was no significant difference in plasma α‐MSH, β‐endorphin, neurotensin, oxytocin, and substance P levels between 149 patients with schizophrenia, 115 patients with BD, and 186 patients with MDD and 350 healthy controls.